Twenty-eight new species of Anastrepha are described and illustrated: A. acca (Bolivia, Peru), A. adami (Peru), A. amplidentata (Bolivia, Peru), A. annonae (Peru), A. breviapex (Peru), A. caballeroi (Peru), A. camba (Bolivia, Peru), A. cicra (Bolivia, Peru), A. disjuncta (Peru), A. durantae (Peru), A. echaratiensis (Peru), A. eminens (Peru), A. ericki (Peru), A. gonzalezi (Bolivia, Peru), A. gu...

Background Mental, neurological, and substance (MNS) use disorders are a leading cause of disability worldwide; specifically in Peru, MNS affect 1 in 5 persons. However, the great majority of people suffering from these disorders do not access care, thereby making necessary the improvement of existing conditions including a major rearranging of current health system structures beyond care deliv...

Although encephalomyocarditis virus (EMCV) infection has been commonly documented among domestic animals, less is known about EMCV transmission among humans. Recently, we described the isolation of EMCV from two febrile patients in Peru. To further investigate EMCV transmission in Peru, we screened febrile patients reporting to health clinics in Peru for serological evidence of recent EMCV infe...

Three new species of "non-spiny" Solanum are described from Peru and Ecuador, and a revised description for Solanum verecundum M. Nee is presented. Solanum kulliwaita S. Knapp, sp. nov. (Dulcamaroid clade) is endemic to the Department of Cuzco in southern Peru, and is most similar to the recently described Solanum sanchez-vegae S. Knapp of northern Peru. Solanum dillonii S. Knapp, sp. nov. (Bre...

A new live oral cholera vaccine, Peru-15, was studied for safety, immunogenicity, and excretion in 2 groups of healthy volunteers. Twelve inpatient volunteers received freshly harvested vaccine in doses of either 10(7) or 10(9) cfu. Subsequently 50 outpatient volunteers received freeze-dried vaccine in doses of 10(8) or 10(9) cfu or placebo in a three-cell, double-masked, placebo-controlled tri...

A live oral Vibrio cholerae O1 El Tor vaccine, Peru-15 was tested in a double-blind, randomized placebo controlled study for safety and immunogenicity in Phase I and Phase II studies in 240 Bangladeshi children aged 9 months-5 years of age. Two different doses (2x10(7) and 2x10(8)cfu) were tested. Vaccination did not elicit adverse events and the strain was genetically stable. Vibriocidal antib...

1Barcelona Centre for International Health Research (CRESIB), Hospital Clinic, University of Barcelona, Barcelona, Spain; 2August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; 3Epidemiology and Public Health (CIBERESP), Spain; 4Peruvian University of Applied Sicences, Lima, Peru; 5Nutricional Institute of Investigation, Lima, Peru; 6Chemical Engineering Department, Mole...

Observers have expressed concern that Chinese mining companies operating in Latin America are more egregious violators of labor and environmental standards than other mining companies. Critics point to the case of one operation in particular—Shougang Hierro Peru—as evidence of China’s threat to Latin American labor and environment. We combine archival research in Peru, personal interviews, and ...

clinical data on 2009 pandemic H1N1 influenza A (pH1N1) from Lima, Peru Yeny Tinoco, Hugo Razuri, Ernesto J. Ortiz, Jorge Gomez, Marc-Alain Widdowson, Timothy Uyeki, Victor Alberto Laguna-Torres, Tadeusz J. Kochel, Robert H. Gilman, and Joel M. Montgomery, for the Peru Influenza Working Group* US Naval Medical Research Center Detachment, Lima, Peru. Peruvian Ministry of Health, Direccion Genera...

In this article we present the essential components and policies that are most relevant regarding the conceptual framework to strengthen the health information systems in Peru. The article also presents the main policies, actions and strategies made in the field of electronic health in Peru that are most significant. The health information systems in Peru play a key role and are expected to ach...